Navigation Links
Northfield Laboratories Inc. Comments on Article and Editorial on Hemoglobin-Based Blood Substitutes to be Published in May 21 JAMA
Date:4/28/2008

EVANSTON, Ill., April 28 /PRNewswire-FirstCall/ -- Northfield Laboratories Inc. (Nasdaq: NFLD). Northfield Laboratories Inc. issued the following statement in response to a May 21 publication in the Journal of the American Medical Association entitled Cell-Free Hemoglobin-Based Blood Substitutes and Risk of Myocardial Infarction and Death: A Meta-analysis and the accompanying editorial released online today.

"Meta-analyses that compare varied products under the umbrella of an entire class are a useful tool to raise questions that may merit answers with respect to the class," said Steven A. Gould, M.D., Chairman and Chief Executive Officer of Northfield Laboratories, Inc. "But it is important to note what meta-analyses cannot accomplish. Meta-analysis is not designed to provide answers about specific products or to examine fully the risk/benefit ratio of any particular product. Rather, that is the role of clinical trials that are focused on a particular product and are conducted to assess its safety and efficacy in relation to a proposed indication. Northfield will present such data on its product, PolyHeme(R) next week at the FDA/NIH-sponsored workshop on Hemoglobin Based Oxygen Carriers (HBOCs.)"

The workshop, sponsored jointly by the Food and Drug Administration and the National Institutes of Health, will be held on April 28 and 29 in Bethesda, Maryland. It will examine the current status and future directions of HBOCs. Steven A. Gould, M.D., will present a talk on the clinical development of PolyHeme(R), Northfield Laboratories' investigational red cell substitute. His talk will include a summary of the clinical studies conducted by the Company and reported to the FDA.

About the Workshop

The two-day public workshop, Hemoglobin-Based Oxygen Carriers: Current Status and Future Directions, is sponsored by the Food and Drug Administration, the National Heart, Lung and Blood Institute of the National Institutes of Health, and the Department of Health and Human Services' Office of the Secretary and Office of Public Health and Science (OS/OPHS). The purpose of the workshop is to gather the available scientific information and hear informed opinion on the safety of HBOCs in relation to a variety of clinical use settings as a basis to advance the field.

About Northfield Laboratories and PolyHeme(R)

Northfield Laboratories Inc. is a leader in developing an oxygen-carrying red blood cell substitute for the treatment of life-threatening blood loss, when an oxygen-carrying fluid is required and red blood cells are not available. Northfield's product, PolyHeme(R), is under clinical investigation as oxygen-carrying red blood cell substitute. It is a solution of chemically modified human hemoglobin that requires no cross matching and is therefore compatible with all blood types. It has a shelf life in excess of 12 months. For further information, visit http://www.northfieldlabs.com.

FOR FURTHER INFORMATION CONTACT:

Sophia H. Twaddell

Vice President, Corporate Communications

(847) 864-3500

stwaddell@northfieldlabs.com


'/>"/>
SOURCE Northfield Laboratories Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Northfield Automation Announces Wholly Owned Subsidiary to Diversify Into Medical Device Market
2. NIOXIN(R) Research Laboratories First to Market HairDX Genetic Test for Womens Hair Loss
3. Caraco Pharmaceutical Laboratories Ltd. Wins Summary Judgment on Generic Ultracet(R)
4. IDEXX Laboratories to Release 2008 First Quarter Financial Results
5. Forest Laboratories, Inc. Reports Fiscal Year 2008 Fourth Quarter Reported EPS of $0.55 Including $0.35 Per Share Charge for Licensing Payment
6. Breckenridge Pharmaceutical Signs Letter of Intent for Long Term Agreement With Orit Laboratories (West Caldwell, NJ)
7. Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2008 Fourth Quarter Earnings
8. Stiefel Laboratories Appoints First Chief Scientific Officer
9. Underwriters Laboratories Management System Registration Business to Merge With Germanys DQS
10. Caraco Pharmaceutical Laboratories Ltd. To Market Generic Ethyol(R)
11. Bond Laboratories First Quarter Fiscal 2008 Sales Exceeding Internal Projections
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Apple ... care services, staged a mock evacuation of the facility as part of a disaster ... Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well as the ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Global Healthcare Management’s ... Alexandria Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s ... The fun run is geared towards children of all ages; it is a ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the ... danger possible to save lost souls in the Philippines. “The Journey: From the Mountains ... a dedicated teacher of the Bible. She has taught all ages and currently teaches ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest and ... plans to open a flagship location in Covington, LA at 401 N. U.S. Highway ... store next to Office Depot in the Holiday Square shopping center. Its location allows ...
(Date:10/12/2017)... ... 2017 , ... Asante, a nationally recognized health system in ... existing home health joint venture through an agreement, effective October 1, 2017, to ... home health company with Asante, delivering clinically integrated care, for the past eight ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... -- NDS received FDA 510(k) clearance in May 2017 for its highly ... designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... support the improvement of patient outcomes, procedural efficiency, and the lowering ... ... ...
(Date:10/4/2017)... 4, 2017  South Korean-based healthcare product Development Company ... "cprCUBE" on Kickstarter. The device will educate the user ... with better efficiency compared to the dated and pricey ... on efficacy of the compression for a more informed ... goal to raise $5,000. ...
(Date:10/2/2017)... 2017  Eli Lilly and Company (NYSE: ... third quarter of 2017 on Tuesday, October 24, 2017. ... day with the investment community and media to further ... call will begin at 9 a.m. Eastern time. Investors, ... webcast of the conference call through a link that ...
Breaking Medicine Technology: